Autoimmune Thrombocytopenia: current treatment options in adults with a focus on novel drugs. A middle range theory of family vigilance. Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids.
Peroxisome proliferator-activated receptor gamma
Mental disorders in systemic lupus erythematosus: a cohort study. Medicolegal characteristics of cardiac tamponade litigation: A review of the LexisNexis academic database. How to start an antimicrobial stewardship programme in a hospital. Does physician gender have a significant impact on first-pass success rate of emergency endotracheal intubation? Nutritional neurobiology and central nervous system sensitisation: missing link in a comprehensive treatment for chronic pain?
Exercise energy expenditure in patients with idiopathic pulmonary arterial hypertension: impact on clinical severity and survival. Kinesio taping in musculoskeletal pain and disability that lasts for more than 4 weeks: is it time to peel off the tape and throw it out with the sweat? A systematic review with meta-analysis focused on pain and also methods of tape application. Impact of scribes on throughput metrics and billing during an electronic medical record transition.
Presenting complaints and mortality in a cohort of 22 adult emergency patients at a local hospital in Nepal.
Peroxisome proliferator-activated receptor gamma - Wikipedia
Efficacy of lung cancer screening appears to increase with prolonged intervention: results from the MILD trial and a meta-analysis. Seroprevelence of rubella among children suspected of having measles in Gadarif Hospital, Eastern Sudan. Marijuana smoking and outcomes of infertility treatment with assisted reproductive technologies. Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis RADIANCE : a multicentre, randomised, month, phase 3 trial.
Existing User Sign In. New to Read Sign Up. PPARa agonists have been reported to reduce blood pressure in clinical trials in humans.
The effect of PPARa agonist on renal vasodilation, sodium excretion and excretion of urinary epoxygenase or monooxygenase products in response to salt loading is not known. The regulation of urinary HETE excretion may be impaired in human hypertension. Other Name: Tricor Drug: Placebo Subjects will be randomized to receive placebo or fenofibrate for five days by mouth Placebo Comparator: Fenofibrate, then placebo Randomized study of fenofibrate versus placebo during high salt intake.
Participants were classified as salt-sensitive if the average study day mean arterial pressure MAP was at least 5 mmHg higher during the high salt placebo arm than during low salt intake. Information from the National Library of Medicine Choosing to participate in a study is an important personal decision.
Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below.
For general information, Learn About Clinical Studies. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. Search for terms x.
- Peroxisome Proliferator Activated Receptors From Basic Science To Clinical Applications.
- Ligand Selectivity of the Peroxisome Proliferator-Activated Receptor α | Biochemistry;
- Login using?
- Weitere vorgeschlagene Titel?
- Original Research ARTICLE.
Save this study. Warning You have reached the maximum number of saved studies Listing a study does not mean it has been evaluated by the U. Federal Government.
nutritiony.com/2744-viber-tracking-for.php Read our disclaimer for details. Results First Posted : June 20, Last Update Posted : June 28, Study Description. The hypothesis is to test to see if the drug fenofibrate will increase important chemicals in the body and specifically in the kidney, help to rid the body of salt by the kidneys, decrease blood pressure and improve insulin sensitivity during high-salt intake in individuals with hypertension. MedlinePlus related topics: Sodium. Drug Information available for: Fenofibrate. FDA Resources. Arms and Interventions. Subjects will be randomized to receive placebo or fenofibrate for five days by mouth.
Randomized study of fenofibrate versus placebo during high salt intake. Outcome Measures. Eligibility Criteria. Contacts and Locations.
Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.